Evaluation of the Effects of Age, Prior Exposure, and Previous Vaccination on the B Cell Response to Inactivated Influenza Vaccine in Healthy Adults and Children
Phase of Trial: Phase IV
Latest Information Update: 13 Mar 2018
Price : $35 *
At a glance
- Drugs GSK 2321138A (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 21 Dec 2017 Status changed from not yet recruiting to recruiting.
- 18 Dec 2017 Planned initiation date changed from 7 Dec 2017 to 4 Jan 2017.
- 09 Nov 2017 Planned initiation date changed from 16 Nov 2017 to 7 Dec 2017.